Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

41%

9 trials in Phase 3/4

Results Transparency

45%

5 of 11 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (8)
P 2 (1)
P 3 (1)
P 4 (8)

Trial Status

Completed11
Unknown4
Recruiting3
Not Yet Recruiting2
Suspended1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06069206Not ApplicableCompleted

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT06426836Not ApplicableRecruiting

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

NCT04666948Phase 4CompletedPrimary

Precision Dosing of Vancomycin in Critically Ill Children

NCT02456974Recruiting

Antibiotic Dosing in Pediatric Intensive Care

NCT06772675Not ApplicableRecruiting

Vancomycin Reduction Practices (VRP) in the NICU

NCT05823116Phase 4CompletedPrimary

Continuous vs. Intermittent Infusion Vancomycin

NCT02667418Phase 4Terminated

Optimal Treatment for Recurrent Clostridium Difficile

NCT07120490Not ApplicableNot Yet Recruiting

STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection

NCT04911270Not ApplicableCompleted

Clinical Decision Support Tool for Vancomycin Dosing in Children

NCT04042233Phase 4Completed

Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol

NCT05257070CompletedPrimary

The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine

NCT05535075Phase 4CompletedPrimary

Model-informed Precision Dosing of Vancomycin in Adults

NCT05964114Not ApplicableNot Yet RecruitingPrimary

First Time Right of Vancomycin

NCT03453684Phase 4Completed

Pharmacokinetics of Preoperative Vancomycin

NCT02590523Phase 3Suspended

Intracameral Antibiotic Safety Study

NCT04756895Not ApplicableCompletedPrimary

Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population

NCT04758442Not ApplicableUnknownPrimary

Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology

NCT03221023Phase 2UnknownPrimary

Intrawound Vancomycin Prophylaxis for Neural Stimulator

NCT03456544UnknownPrimary

Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China

NCT03806543CompletedPrimary

The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level

Scroll to load more

Research Network

Activity Timeline